Is bypassing regulatory oversight, including evaluation, the answer to solving medicines shortages that were caused by not only dollar shortages but sheer inefficiency, lethargy, lack of coordination and procrastination? Are walk-in offers by unregistered pharma companies ok?
https://twitter.com/nimilamalee/status/1623588640764104704
While grateful for #India's credit line for medical supplies, and while appreciating that it mandates procurement via #Indian companies, did India ask #SriLanka to bypass regulatory oversight?
Did #Indian suppliers influence #SriLanka's health ministry to list all manner of non-essential, non-urgent medicines, including shampoo and cough medicines, on the procurement lists? If not, why is Sri Lanka borrowing for such items when even vital cancer drugs are unavailable?
If the health ministry starts popularising this method for drugs procurement, what incentive is there to return the stringent but necessary regulation of medical supplies? Then what happens to medical oversight? Why should any company follow the rules?
Why did the National Medicines Regulatory Authority (NMRA) chairman and CEO participate in this fiasco, rubberstamping the ministry's/minister's requests? Is it time to examine how these positions are filled?
What action outside of entertaining unsolicited proposals has the minister/ministry taken to improve procurement under regular procedures?
• • •
Missing some Tweet in this thread? You can try to
force a refresh
